Metabolomic Profiles, Ideal Cardiovascular Health, and Risk of Heart Failure and Atrial Fibrillation: Insights From the Framingham Heart Study
Yi Li(Boston University), Deepa M. Gopal(Boston University), Jessica L. Fetterman(Boston University), Melissa G. Farb(Boston University), Nir Ayalon(Boston University), Ayana R Gray(Harvard University), Vanessa Xanthakis(Framingham Heart Study), Ramachandran S. Vasan(The University of Texas at San Antonio Health Science Center), Martin G. Larson(Boston University), Daniel Levy(National Heart Lung and Blood Institute), Darae Ko(Boston University), Liying Xue(Broad Institute), Chunyu Liu(Southwest Medical University), Jian Rong(National Heart Lung and Blood Institute), Emelia J. Benjamin(Boston University), Charlotte Andersson(Herlev Hospital)
Cited by 35
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
Prediction of Coronary Heart Disease Using Risk Factor Categories
|Circulation|1998|9.6k
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
|Circulation|2020|9.4k